Justem Grants 5,000 Stock Options to an Executive: Minimal Impact on Shareholder Value
Justem decided on May 27, 2026, via board resolution, to grant 5,000 common stock options (exercise price: 15,364 won) to one executive for talent retention.
The exercise price, calculated as the arithmetic average of volume-weighted average prices over 2 months, 1 month, and 1 week prior to the board meeting, is about 18% below the current stock price of 18,790 won, representing a discounted issuance.
The options, issued as new shares, are exercisable from May 27, 2028 to May 26, 2035, aimed at linking individual compensation with shareholder value improvement.
The grant size is only 0.02% of total outstanding shares (22,663,931), resulting in negligible dilution in the near term. However, the absence of dividends for the past three years highlights limited shareholder returns.
The fair value per option is estimated at 14,906 won, leading to a total expense of approximately 74.5 million won, subject to audit adjustments.
[AI Comprehensive Analysis]The stock option grant is too small to materially affect the stock price or corporate value. However, the discounted exercise price poses a slight dilution risk, and the lack of dividends underscores the need for enhanced shareholder-friendly policies.